Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence-Reference-Cited by-同舟云学术

Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence

Published:2023-08 Issue: Volume:570 Page:216307
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Qin Yi,Ashrafizadeh Milad,Mongiardini Vera,Grimaldi Benedetto,Crea Francesco,Rietdorf Katja,Győrffy Balázs,Klionsky Daniel J.,Ren Jun,Zhang Wei,Zhang Xianbin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference225 articles.

1. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications;Shibue;Nat. Rev. Clin. Oncol.,2017

2. Toward understanding and exploiting tumor heterogeneity;Alizadeh;Nat. Med.,2015

3. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance;Easwaran;Mol. Cell.,2014

4. The causes and consequences of genetic heterogeneity in cancer evolution;Burrell;Nature,2013

5. Cancer genome landscapes;Vogelstein;Science,2013

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer;Non-coding RNA Research;2025-02

2. Acidic sphingomyelinase interactions with lysosomal membranes and cation amphiphilic drugs: A molecular dynamics investigation;Computational and Structural Biotechnology Journal;2024-12

3. Excavating regulated cell death signatures to predict prognosis, tumor microenvironment and therapeutic response in HR+/HER2- breast cancer;Translational Oncology;2024-12

4. Exosomal miR-4516 derived from ovarian cancer stem cells enhanced cisplatin tolerance in ovarian cancer by inhibiting GAS7;Gene;2024-11

5. Chiral inorganic nanomaterials in the tumor microenvironment: A new chapter in cancer therapy;Pharmacological Research;2024-10